Search details
1.
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection.
Cell Mol Life Sci
; 79(11): 582, 2022 Nov 05.
Article
in English
| MEDLINE | ID: mdl-36334153
2.
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.
Cancer Immunol Immunother
; 68(10): 1689-1700, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31375885
3.
Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
Int J Cancer
; 133(11): 2522-32, 2013 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23686552
4.
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.
Oncoimmunology
; 12(1): 2152998, 2023.
Article
in English
| MEDLINE | ID: mdl-36531688
5.
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.
Oncoimmunology
; 11(1): 2069214, 2022.
Article
in English
| MEDLINE | ID: mdl-35529675
6.
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma.
Cancers (Basel)
; 13(15)2021 Aug 03.
Article
in English
| MEDLINE | ID: mdl-34359808
7.
Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.
J Immunother Cancer
; 8(1)2020 06.
Article
in English
| MEDLINE | ID: mdl-32571994
8.
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC.
J Immunother Cancer
; 8(2)2020 11.
Article
in English
| MEDLINE | ID: mdl-33199511
9.
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Clin Transl Med
; 14(4): e1617, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38664548
Results
1 -
9
de 9
1
Next >
>>